Jayamas Medica Valuation
| OMED Stock | 184.00 1.00 0.54% |
At this time, the firm appears to be overvalued. Jayamas Medica Industri retains a regular Real Value of USD153.09 per share. The prevalent price of the firm is USD184.0. Our model calculates the value of Jayamas Medica Industri from evaluating the firm fundamentals such as Current Valuation of 5.63 T, return on equity of 0.52, and Return On Asset of 0.29 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Jayamas Medica's price fluctuation is very steady at this time. Calculation of the real value of Jayamas Medica Industri is based on 3 months time horizon. Increasing Jayamas Medica's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Jayamas Medica's intrinsic value may or may not be the same as its current market price of 184.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 184.0 | Real 153.09 | Hype 184.0 |
The intrinsic value of Jayamas Medica's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Jayamas Medica's stock price.
Estimating the potential upside or downside of Jayamas Medica Industri helps investors to forecast how Jayamas stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Jayamas Medica more accurately as focusing exclusively on Jayamas Medica's fundamentals will not take into account other important factors: Jayamas Medica Total Value Analysis
Jayamas Medica Industri is now forecasted to have takeover price of 5.63 T with market capitalization of 5.9 T, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Jayamas Medica fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.63 T | 5.9 T |
Jayamas Medica Investor Information
The company recorded earning per share (EPS) of 16.47. Jayamas Medica Industri had not issued any dividends in recent years. Based on the key measurements obtained from Jayamas Medica's financial statements, Jayamas Medica Industri is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Jayamas Medica Asset Utilization
One of the ways to look at asset utilization of Jayamas is to check how much profit was generated for every dollar of assets it reports. Jayamas Medica harnesses its resources almost 0.29 (percent), generating USD0.002915 for each dollar of resources held by the firm. A positive asset utilization attests that the company is slightly more effective with each dollar of resources it retains. Simply put, asset utilization of Jayamas Medica shows how effective it operates for each dollar spent on its resources.Jayamas Medica Ownership Allocation
Jayamas Medica Industri has a total of 27.06 Billion outstanding shares. Jayamas Medica retains 8.0 (percent) of its outstanding shares held by insiders and 0.47 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Jayamas Medica Profitability Analysis
The company reported the revenue of 2.19 T. Net Income was 562.69 B with profit before overhead, payroll, taxes, and interest of 904.29 B.About Jayamas Medica Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Jayamas Medica Industri. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Jayamas Medica Industri based exclusively on its fundamental and basic technical indicators. By analyzing Jayamas Medica's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Jayamas Medica's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Jayamas Medica. We calculate exposure to Jayamas Medica's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Jayamas Medica's related companies.8 Steps to conduct Jayamas Medica's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Jayamas Medica's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Jayamas Medica's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Jayamas Medica's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Jayamas Medica's revenue streams: Identify Jayamas Medica's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Jayamas Medica's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Jayamas Medica's growth potential: Evaluate Jayamas Medica's management, business model, and growth potential.
- Determine Jayamas Medica's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Jayamas Medica's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Jayamas Stock
Jayamas Medica financial ratios help investors to determine whether Jayamas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jayamas with respect to the benefits of owning Jayamas Medica security.